Substance Use in Assault-Injured Young Adults
Alcohol and Cannabis Use Among Assault-Injured Emerging Adults
2 other identifiers
interventional
50
1 country
1
Brief Summary
This study aims to improve a short motivational conversation to better help young adults who were injured in assaults and also use alcohol or cannabis. Researchers will gather both interview and survey data from young adults who came to the emergency department after an assault and currently use alcohol or cannabis. Guided by a theory about risky behaviors, the study will focus on how confident young people feel about making changes to their alcohol and cannabis use, and how their friends and family influence their alcohol and cannabis use and involvement in injuries from assault. The team will follow a step-by-step process used by the NIH to adapt and test the improved motivational conversation in the emergency department.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2025
CompletedFirst Posted
Study publicly available on registry
July 17, 2025
CompletedStudy Start
First participant enrolled
August 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2028
Study Completion
Last participant's last visit for all outcomes
February 1, 2028
November 3, 2025
October 1, 2025
1.5 years
July 8, 2025
October 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Feasibility assessed by recruitment
Recruitment measured as the percentage of those invited/those who enrolled
Day 0 and 30
Feasibility assessed by randomization
Recruitment measured as the percentage of screened eligible participants who enroll/those who receive either intervention or control arm
Day 0 and 30
Feasibility assessed by retention
Recruitment measured as the percentage of those enrolled who have received either intervention or control arm/ participants who have completed all 30-day follow up assessments
Day 0 and 30
Acceptability assessed by Acceptability of Intervention Measure (AIM)
Acceptability of the intervention will be assessed using the Acceptability of Intervention Measure (AIM). It has 4-items scored on a 5-point Likert scale summed to achieve a total score. Total score range of 0-20. Higher scores indicate more acceptability.
Day 0
Study Arms (2)
Brief Negotiation Interview intervention (BNI) (adapted)
EXPERIMENTALParticipants randomized to the intervention arm will receive a brief motivational interview designed to increase motivation to reduce alcohol and/or cannabis use and engagement in treatment referral at 30-days. A referral includes a contact number to addiction treatment (primary care and/or specialty addiction care consistent with diagnostic criteria) and injury prevention services at the Yale Hospital Violence Intervention Program.
Control Group
NO INTERVENTIONControl group will receive contact referrals only. A referral includes a contact number to addiction treatment (primary care and/or specialty addiction care consistent with diagnostic criteria) and injury prevention services at the Yale Hospital Violence Intervention Program.
Interventions
A brief motivational interview designed to increase motivation to reduce alcohol and/or cannabis use and engagement in treatment referral.
Eligibility Criteria
You may qualify if:
- Aim 1:
- Be clients of the Yale Hospital Violence Intervention Program (YHVIP)
- Be between the ages of 18-25 y/o upon study enrollment
- Have sustained an intentional injury inflicted by another person not considered to be a boy/girlfriend, fiancée, or spouse in the past year
- Report current alcohol and/or cannabis misuse
- Be English-speaking and able to provide informed consent.
- Aim 2 and 3:
- Present to Yale New Haven Hospital ED for an intentional injury inflicted by another person not considered to be a boy/girlfriend, fiancée, or spouse
- Be between the ages of 18-25 y/o upon study enrollment
- Report current alcohol and/or cannabis misuse
- Be English-speaking and able to provide informed consent.
You may not qualify if:
- Aim 1:
- Be actively suicidal or severely cognitively impaired precluding informed consent
- Sustain an intentional injury from a boy/girlfriend, fiancée, or spouse or sexual assault
- Be incarcerated or in police custody
- Currently engaged in addiction treatment
- Aim 2 and 3:
- Be actively suicidal or severely cognitively impaired precluding informed consent
- Sustain intentional injury from a boy/girlfriend, fiancée, spouse or by sexual assault
- Be incarcerated or in police custody
- Currently engaged in addiction treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Yale Department of Emergency Medicine
New Haven, Connecticut, 06520, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edouard Coupet, MD, MS
Yale University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2025
First Posted
July 17, 2025
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2028
Last Updated
November 3, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will share
De-identified individual-level data will be shared 6 months after publication for up to 3 years